Table 1.
Clinicopathological features of the analyzed patients
| All Analyzed Patients | Patients by OS |
P | ||
|---|---|---|---|---|
| ≤Median (n = 31) | >Median (n = 30) | |||
| Age, y | ||||
| Median (q1;q3) | 65.5 (54;71) | 70 (63;75) | 57 (53;68) | .002 |
| Gender, n (%) | ||||
| Men | 47 (65.3) | 21(50.0) | 21 (50.0) | |
| Women | 25 (34.7) | 10 (52.6) | 9 (47.4) | 1 |
| Resection grade, n (%) | ||||
| Total | 41 (56.9) | 13 (37.1) | 22 (62.9) | |
| Nontotal | 31(43.1) | 18 (69.2) | 8 (30.8) | .02 |
| Therapy, n (%) | ||||
| With temozolomide | 49 (68.1) | 10 (26.3) | 28 (73.7) | |
| Without temozolomide | 18 (25.0) | 17 (94.4) | 1 (5.6) | .02 |
| Unknown | 5 (6.9) | 4 (80.0) | 1 (20.0) | |
| Vital status, n (%) | ||||
| Deceased | 62 (86.1) | |||
| Alive | 10 (13.9) | |||
*For 1 patient date of death unknown.